{"ticker": {"uuid": "8ccaf556-4546-4a8f-8dbf-1bca77893b32", "symbol": "CHOSA", "name": "CHOSA Oncology AB", "exchange": "STO", "country": "SE", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Chosa Oncology receives SEK 2.8m from warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQR2MzckU0YWg1V1V6ZUw5NE1FdUhaSVFJeFJEMld4dk1JalRzTE5wVUJWbF9lOTQ4QXJLM195ZWE4dXdvMy1RMVE2MTFnbmpzLUNBcE50dFN0bE5xc3h4c0g5OE1hZkhTcnB1a2R0S2lqOUx5VjgwdU9iaFJBb0dhdWZVaU1lajhEbi1kWXpHN002QzY5STkxTUFoMXpnNzFh?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-15T13:01:32+00:00", "published_display": "15 Jul 2026 13:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chosa recruits Bill Cronin for US expansion", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNc2NFZXRKSkZNaGFySkV6c3Q4YmxkMzhHQUFwMEoxWk5oQmdOZ2xFQXd5VjBxZlF3WHNRQWZpS1c1WjUybkdXaDBqcGNGU3RpaHVMeVhiT3hzOTd2X29aekR4SEU0WXk4QlR0cldSOWJEVG85U2xsTTZib1FMam5BVDA2bWFkOEU5RDFPYWFvSzE5OE5WbzdMRi1PZFE?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-10T06:36:49+00:00", "published_display": "10 Jul 2026 06:36", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CHOSA: CHOSA Oncology appoints US commercialization Bill Cronin with a broad network in the oncology market, to accelerate launch of Platin-DRP", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxNaWVuUkxhamwwZ2VwUDdoMUNTVUsxYm5NRXNHQ0V2cy1CeWZrM2I0b3lIWVNfYmhIUF9hRWxDcmg3ODdHZ3U2XzM5MUpKQjdVSTQ3VVQxczA2VGtoYkxpSlFHUWprTDItaDJTNFAycDI0Q1pONzBVaWVFQ1BBZTBBWGpieFNMb3Z0ZHdDQ3VoY2FJSUFDNDktLS1oeDV6a1NISWQxeDRvYW53TkR0OG9pdDc4bUJkZzMxNnFzQzhlQ3ZucXp1eThFYmtpbUZWYUFldnBrMlNNS0gxdExwX3B6Wm5uNHBmWGs?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-10T06:36:06+00:00", "published_display": "10 Jul 2026 06:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Denmark's Chosa Oncology moves to Boston to adapt cancer test for US market \u2014 and make it marketable", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE90SjRnejF6bDV3UWRlUno2QlNDaGZXVXhHcnlxTjdvS3BQYTUwM0ViZnlpTjZOWUlyWmFsa2FORWpHU2EtZXo0amgzR3NEVXcxb0t6OHpyeXdpT3NkZmZWYl9zWS15Zk1j?oc=5", "source_name": "medwatch.com", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chosa Oncology Begins Subscription Period for Warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPbmtpckk5NFhwcmdsWkhoalgzOVVKanAzQWxOekY0R0ZzM0FwU2p1a21JOTZ4WkZLQkxDRlBsamN3T1AyT2VZd2xwTTNObGdRSFFQcXI1eVVkZGV4Qlp3U3BkWWlKNjM4R1dES1lNQ1U5aDN1RUZXRkxzSVktb1VZNlRCb1lYZjQ5R3NqTlBXaU9SaXhoblV1UDd3ZmEyOEVhRXF0Z1BzRmJZdms?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bulletin from the annual general meeting on 13 June 2025 in Chosa Oncology AB", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxPbGVTdk9hSmYtcUhrSXlGYmFQNzFqNmhvZW9KUjYxRWNnLXkxMTYxQzZrQXdYbXVVM3h0S1lQakYxbk16bXFzQUstTDBqdHJKMmN3Z0ZQRzBacVhjdU1FVzUtazFPbFN3a3VPbkVkR0lvcm9tVzF6ckJMcS1QU3ZKVmRzcF9ZTThybk50QlVhak9rcld6am5xVC1Cc05yNFRGX1pDdE1rZGk3ZmN3T2pBTS0xejRJemJWUFZJTGpqQlJZTEd6anUzRkNlZkppeUdtTzF0bmE4cnBVWVQ1dTBMczc2b1hNNzFr?oc=5", "source_name": "TradingView", "published_at": "2025-06-13T07:00:00+00:00", "published_display": "13 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioStock Investor Pitch: Chosa Oncology", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5xSC1lQThkMjIzZWwwQy1KOE9FR1lWMVNqbzBGUVppMldFMThLTE1ZNXAyVVdFRXR1S1VTR0k0ZlViTm45eVZGb2NMX1R3S3dheXRUYkQ0c0luOThXSXB0NmNzSkQ5UWNGbHQtbmR1QVpYWWFTQXc5YzZlclhpLTQ?oc=5", "source_name": "Biostock", "published_at": "2025-06-02T07:00:00+00:00", "published_display": "02 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chosa develops next generation chemotherapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxQNlBZV3FnSTNqLUZKNnRKY3RTYXc2RTJ0VnV5SldnQlVOVktSam9PZ25oaGtsTF9DY2dpUThFQ3FuLTBSUkNNZ2RzbWVnMXZUNENjQW9iLXNjRUlJYjEzWnZ1c1R2aTJSVHZQMTVkdHhqbGxmTS1mZGtId3M0cTE1bjRKS2s?oc=5", "source_name": "Biostock", "published_at": "2025-05-17T03:06:09+00:00", "published_display": "17 May 2025 03:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GLP Japan Boss Chosa to Speak at Mingtiandi Tokyo Forum", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNdVpmcWRTZGhDOWZTRjBTcnNuMXZVc2Rlc1VXbzRYV0paRnFWSS1DcFlETUFycENrLXdnUWJSSU9uZXY5ak9XZ0RoVWM0V0JocGtLX0loTlB3bXdVdmZFSkJCVG85UG8xTWt3QWJuN2VwQUJrVkFuWTdhSjZoNXUyWHh3WVFRU2FKSmoweG9fNnRBWE50bFlCVVlBQVp1TUlRUnRZZw?oc=5", "source_name": "Mingtiandi", "published_at": "2024-10-28T07:00:00+00:00", "published_display": "28 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CHOSA Stock Price and Chart \u2014 NGM:CHOSA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE1aRzBTNXVEUS1EaGFweVN0c200c2xlOXQ0d1k4QTVfREQ1eWlDMXQ1blNiVXdpV1ZDcmZ5eG5yMGhwcXVTX1ZMRlFqeGozRjMtVEc5UmlBb2dpdw?oc=5", "source_name": "TradingView", "published_at": "2023-02-16T16:12:28+00:00", "published_display": "16 Feb 2023 16:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chosa Oncology's CEO about the company and its development", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxNOWpXOWFsRnAzcUVaWkVKSUFONE05X3VjRnJqd2lEYWpDV205bkFLVjRIME9tTS14dHFpU3RDVDJ6Uk5qWFdPVHVNNlZkN0lpSVhyajdKWHFJRG04TU5jVWx1RkoydDRQc3pWMm1NZ3pxbE1YMThaR3FWM0daRHlnQVExV1U?oc=5", "source_name": "Biostock", "published_at": "2023-01-26T08:00:00+00:00", "published_display": "26 Jan 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RhoVac becomes Chosa Oncology after acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPVGp1bE95Ry1ZX1ZsNGwtYzhoOTZHYlViLXdWbmJBRlFLLW9NRGlCTzVPd1g2X0hGeXZTS3NuR3VZZWVrQ0tEa0tYWWRMcnh2V1NOQUdJRUdna3o0eUZIUlNUQ0F3UEZmbDgwMk9ObVRJbVRoOGk2b2JZYWxyOGk0Y1VURTlQT0ZsbHQ1THBkSQ?oc=5", "source_name": "Biostock", "published_at": "2023-01-20T09:55:36+00:00", "published_display": "20 Jan 2023 09:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chosa Oncology gets Chinese patent green light", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQQlR3d0FfY25Qak80OTY0MVVPNTlPVXBBWmhsbkYwMEJabE51QW4wOWk3WlJkNDlBUndBNTZGZ29hMmwwNzZoNldxUE4tVXZQc1EydC1EcHhNZk0xdi1jR2E1OGN5RWx0eGJwLXBYbmU0YmtUcEFCakdlLVdzbE0wdzR6NWxVLTZX?oc=5", "source_name": "Biostock", "published_at": "2022-12-23T08:00:00+00:00", "published_display": "23 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Chosa Oncology receives SEK 2.8m from warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQR2MzckU0YWg1V1V6ZUw5NE1FdUhaSVFJeFJEMld4dk1JalRzTE5wVUJWbF9lOTQ4QXJLM195ZWE4dXdvMy1RMVE2MTFnbmpzLUNBcE50dFN0bE5xc3h4c0g5OE1hZkhTcnB1a2R0S2lqOUx5VjgwdU9iaFJBb0dhdWZVaU1lajhEbi1kWXpHN002QzY5STkxTUFoMXpnNzFh?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-15T13:01:32+00:00", "published_display": "15 Jul 2026 13:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chosa recruits Bill Cronin for US expansion", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNc2NFZXRKSkZNaGFySkV6c3Q4YmxkMzhHQUFwMEoxWk5oQmdOZ2xFQXd5VjBxZlF3WHNRQWZpS1c1WjUybkdXaDBqcGNGU3RpaHVMeVhiT3hzOTd2X29aekR4SEU0WXk4QlR0cldSOWJEVG85U2xsTTZib1FMam5BVDA2bWFkOEU5RDFPYWFvSzE5OE5WbzdMRi1PZFE?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-10T06:36:49+00:00", "published_display": "10 Jul 2026 06:36", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CHOSA: CHOSA Oncology appoints US commercialization Bill Cronin with a broad network in the oncology market, to accelerate launch of Platin-DRP", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxNaWVuUkxhamwwZ2VwUDdoMUNTVUsxYm5NRXNHQ0V2cy1CeWZrM2I0b3lIWVNfYmhIUF9hRWxDcmg3ODdHZ3U2XzM5MUpKQjdVSTQ3VVQxczA2VGtoYkxpSlFHUWprTDItaDJTNFAycDI0Q1pONzBVaWVFQ1BBZTBBWGpieFNMb3Z0ZHdDQ3VoY2FJSUFDNDktLS1oeDV6a1NISWQxeDRvYW53TkR0OG9pdDc4bUJkZzMxNnFzQzhlQ3ZucXp1eThFYmtpbUZWYUFldnBrMlNNS0gxdExwX3B6Wm5uNHBmWGs?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-10T06:36:06+00:00", "published_display": "10 Jul 2026 06:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Denmark's Chosa Oncology moves to Boston to adapt cancer test for US market \u2014 and make it marketable", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE90SjRnejF6bDV3UWRlUno2QlNDaGZXVXhHcnlxTjdvS3BQYTUwM0ViZnlpTjZOWUlyWmFsa2FORWpHU2EtZXo0amgzR3NEVXcxb0t6OHpyeXdpT3NkZmZWYl9zWS15Zk1j?oc=5", "source_name": "medwatch.com", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chosa Oncology Begins Subscription Period for Warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPbmtpckk5NFhwcmdsWkhoalgzOVVKanAzQWxOekY0R0ZzM0FwU2p1a21JOTZ4WkZLQkxDRlBsamN3T1AyT2VZd2xwTTNObGdRSFFQcXI1eVVkZGV4Qlp3U3BkWWlKNjM4R1dES1lNQ1U5aDN1RUZXRkxzSVktb1VZNlRCb1lYZjQ5R3NqTlBXaU9SaXhoblV1UDd3ZmEyOEVhRXF0Z1BzRmJZdms?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bulletin from the annual general meeting on 13 June 2025 in Chosa Oncology AB", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxPbGVTdk9hSmYtcUhrSXlGYmFQNzFqNmhvZW9KUjYxRWNnLXkxMTYxQzZrQXdYbXVVM3h0S1lQakYxbk16bXFzQUstTDBqdHJKMmN3Z0ZQRzBacVhjdU1FVzUtazFPbFN3a3VPbkVkR0lvcm9tVzF6ckJMcS1QU3ZKVmRzcF9ZTThybk50QlVhak9rcld6am5xVC1Cc05yNFRGX1pDdE1rZGk3ZmN3T2pBTS0xejRJemJWUFZJTGpqQlJZTEd6anUzRkNlZkppeUdtTzF0bmE4cnBVWVQ1dTBMczc2b1hNNzFr?oc=5", "source_name": "TradingView", "published_at": "2025-06-13T07:00:00+00:00", "published_display": "13 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BioStock Investor Pitch: Chosa Oncology", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5xSC1lQThkMjIzZWwwQy1KOE9FR1lWMVNqbzBGUVppMldFMThLTE1ZNXAyVVdFRXR1S1VTR0k0ZlViTm45eVZGb2NMX1R3S3dheXRUYkQ0c0luOThXSXB0NmNzSkQ5UWNGbHQtbmR1QVpYWWFTQXc5YzZlclhpLTQ?oc=5", "source_name": "Biostock", "published_at": "2025-06-02T07:00:00+00:00", "published_display": "02 Jun 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chosa develops next generation chemotherapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxQNlBZV3FnSTNqLUZKNnRKY3RTYXc2RTJ0VnV5SldnQlVOVktSam9PZ25oaGtsTF9DY2dpUThFQ3FuLTBSUkNNZ2RzbWVnMXZUNENjQW9iLXNjRUlJYjEzWnZ1c1R2aTJSVHZQMTVkdHhqbGxmTS1mZGtId3M0cTE1bjRKS2s?oc=5", "source_name": "Biostock", "published_at": "2025-05-17T03:06:09+00:00", "published_display": "17 May 2025 03:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GLP Japan Boss Chosa to Speak at Mingtiandi Tokyo Forum", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNdVpmcWRTZGhDOWZTRjBTcnNuMXZVc2Rlc1VXbzRYV0paRnFWSS1DcFlETUFycENrLXdnUWJSSU9uZXY5ak9XZ0RoVWM0V0JocGtLX0loTlB3bXdVdmZFSkJCVG85UG8xTWt3QWJuN2VwQUJrVkFuWTdhSjZoNXUyWHh3WVFRU2FKSmoweG9fNnRBWE50bFlCVVlBQVp1TUlRUnRZZw?oc=5", "source_name": "Mingtiandi", "published_at": "2024-10-28T07:00:00+00:00", "published_display": "28 Oct 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CHOSA Stock Price and Chart \u2014 NGM:CHOSA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE1aRzBTNXVEUS1EaGFweVN0c200c2xlOXQ0d1k4QTVfREQ1eWlDMXQ1blNiVXdpV1ZDcmZ5eG5yMGhwcXVTX1ZMRlFqeGozRjMtVEc5UmlBb2dpdw?oc=5", "source_name": "TradingView", "published_at": "2023-02-16T16:12:28+00:00", "published_display": "16 Feb 2023 16:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chosa Oncology's CEO about the company and its development", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxNOWpXOWFsRnAzcUVaWkVKSUFONE05X3VjRnJqd2lEYWpDV205bkFLVjRIME9tTS14dHFpU3RDVDJ6Uk5qWFdPVHVNNlZkN0lpSVhyajdKWHFJRG04TU5jVWx1RkoydDRQc3pWMm1NZ3pxbE1YMThaR3FWM0daRHlnQVExV1U?oc=5", "source_name": "Biostock", "published_at": "2023-01-26T08:00:00+00:00", "published_display": "26 Jan 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RhoVac becomes Chosa Oncology after acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPVGp1bE95Ry1ZX1ZsNGwtYzhoOTZHYlViLXdWbmJBRlFLLW9NRGlCTzVPd1g2X0hGeXZTS3NuR3VZZWVrQ0tEa0tYWWRMcnh2V1NOQUdJRUdna3o0eUZIUlNUQ0F3UEZmbDgwMk9ObVRJbVRoOGk2b2JZYWxyOGk0Y1VURTlQT0ZsbHQ1THBkSQ?oc=5", "source_name": "Biostock", "published_at": "2023-01-20T09:55:36+00:00", "published_display": "20 Jan 2023 09:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chosa Oncology gets Chinese patent green light", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxQQlR3d0FfY25Qak80OTY0MVVPNTlPVXBBWmhsbkYwMEJabE51QW4wOWk3WlJkNDlBUndBNTZGZ29hMmwwNzZoNldxUE4tVXZQc1EydC1EcHhNZk0xdi1jR2E1OGN5RWx0eGJwLXBYbmU0YmtUcEFCakdlLVdzbE0wdzR6NWxVLTZX?oc=5", "source_name": "Biostock", "published_at": "2022-12-23T08:00:00+00:00", "published_display": "23 Dec 2022 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 67, "total_relevant": 13, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 12, "score": 51, "total": 13, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 92, "events": [{"event": "general", "label": "Market update", "weight": 6.6, "count": 12}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 1, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.79, "latest_week": "2026-07-10", "one_week_move": -3.9, "four_week_move": -9.6, "twelve_week_move": -20.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.105265, "market_dynamics_buy_signal": false, "relative_strength": -24.391016, "fair_value_gap": -7.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 40.8739, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.9% over one week, -9.6% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 63, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Biostock", "count": 5}, {"label": "marketscreener.com", "count": 4}, {"label": "TradingView", "count": 2}, {"label": "medwatch.com", "count": 1}, {"label": "Mingtiandi", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 13}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "92/100 classification confidence."}, {"label": "Company focus", "value": "13", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.9% over one week, -9.6% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Chosa Oncology receives SEK 2.8m from warrants"}], "updated_at": "2026-07-17T18:48:18.647835+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}